Delivery Order SPE2DB25D7067-SPE2DB25FSVWC
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order (Contract 4569317131) valued at $3,449.50 to AmerisourceBergen Drug Corp on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price delivery order, which is a child contract to a larger indefinite delivery vehicle, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $1,247.80 by the Defense Logistics Agency's Medical Supply Chain on September 8, 2025. This competitively awarded, firm fixed-price delivery order is unset-aside and has an ultimate completion date of September 9, 2025. The contract represents a child order issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $52,252.74 by the Defense Logistics Agency's Medical Supply Chain on September 1, 2025, with a completion date of September 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $41,791.72 on August 25, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price contract, which is not set-aside and was competitively awarded, is scheduled for ultimate completion on August 26, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $67,151.06 by the Defense Logistics Agency's Medical Supply Chain on September 4, 2025, with an ultimate completion date of September 5, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. This delivery order represents a child contract under AmerisourceBergen's...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $17,056.07 to AmerisourceBergen Drug Corp on August 25, 2025, with completion expected by August 26, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,260.24 to AmerisourceBergen Drug Corp on July 31, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order, issued under a non-competitive, non-set-aside procurement, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The order will be performed at the company's corporate office in Conshohocken, Pennsylvania. As a major...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order contract valued at $2,383.53 to AmerisourceBergen Drug Corp on September 10, 2025, with completion scheduled for September 11, 2025. This firm fixed price, non-set-aside delivery order represents a child contract under AmerisourceBergen's substantial indefinite delivery contract (IDC) with DLA Troop Support Medical valued at $999.99 million through December 2026. The awardee, headquartered in Conshohocken,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award valued at $3,082.67 from the Defense Logistics Agency's Medical Supply Chain on August 24, 2025. This competitively awarded, firm fixed-price contract carries an ultimate completion date of August 25, 2025, and represents a child delivery order under a larger indefinite delivery contract vehicle. The delivery order is not set-aside and reflects AmerisourceBergen's ongoing role as a...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $34,139.94 to AmerisourceBergen Drug Corp on September 1, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price, competitively awarded delivery order (Contract No. 4569285368) is being performed at the company's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger indefinite delivery vehicle, this award represents one of numerous...
- SPE2DB25D7067Indefinite Delivery Contract
- SPE2DB25D7067-SPE2DB25FSVWCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,770.55 to AmerisourceBergen Drug Corp on September 10, 2025, with a completion date of September 11, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The work will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a global pharmaceutical support vehicle enabling the company to supply medical commodities across multiple therapeutic domains to support military healthcare programs worldwide. The contract demonstrates AmerisourceBergen's capability to compete successfully in open competition for federal pharmaceutical procurement and reflects the Defense Logistics Agency's reliance on the contractor as part of its medical supply chain supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.